More About Our Partners
The American College of Rheumatology (ACR)
The Arthritis Foundation and the American College of Rheumatology (ACR) have a long-standing partnership concentrating on increased patient and professional education, government funding of arthritis research through NIAMS, access to appropriate healthcare from qualified pediatric and adult rheumatologists, and aiding access to effective medication and other treatment options. Learn more.
Childhood Arthritis and Rheumatology Research Alliance (CARRA)
The Childhood Arthritis & Rheumatology Research Alliance (CARRA) is a national organization of pediatric rheumatologists committed to advancing the health and quality of life of children living with rheumatic disease. With financial support from the Arthritis Foundation, the American College of Rheumatology (ACR) and others, CARRA's network of pediatric rheumatology research centers provides an accessible point of entry for patients and families across the United States and Canada to participate in research studies and trials of new therapies. Learn more.
Patients, Advocates & Rheumatology Teams Network for Research & Service (PARTNERS)
PARTNERS formally links childhood arthritis and lupus patients, family members, the CARRA network, the Lupus Foundation of America, the Arthritis Foundation and a quality improvement network called PR-COIN. Our vision is to improve the lives of children with rheumatic diseases through research that matters to YOU. PARTNERS is a patient-powered research network funded by PCORI. Learn more!
Centers for Disease Control and Prevention (CDC)
The Arthritis Foundation and the CDC joined together to launch "A National Public Health Agenda for Osteoarthritis." This blueprint for action recommended reducing the burden of osteoarthritis (OA) using four intervention areas:
- Self-management education
- Physical activity
- Injury prevention
- Weight management
National Institutes for Arthritis, Muscoloskeletal and Skin Diseases (NIAMS)
The Arthritis Foundation played an integral part in lobbying for the creation of NIAMS and continues to advocate for its continued and increased funding from Congress every year. The Arthritis Foundation and NIAMS have partnered on many projects through the years, including a recent funding agreement, where the Arthritis Foundation has committed almost $500,000 to fund new genetic research that could revolutionize the way in which rheumatoid arthritis is diagnosed and treated. Learn more!